Quick Hits: Weight Loss Drug Linked to Cancer

Clinical trials showed an increased risk of cancer in patients who took an oral medication intended for obese adults.

When the risks associated with a drug outweigh the benefits, it’s time to pull it from the market. According to a recent CNN article, that was the case with Belviq, a prescription weight loss drug from Eisai Co. Last month, the FDA announced it would be reviewing trial results of the drug, also known as lorcaserin, to determine if it’s linked to an increased risk of cancer. Later, the FDA divulged that clinical trials of Belviq increased the risk of a variety of cancers including pancreatic, colorectal, and lung. 

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report